🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Popularity Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the UK is worrisome and could result in users administering substances of uncertain source.

Some experts said the popularity for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Content Elimination

Based on the social media company, the platform has taken down violative content and banned related keywords and search suggestions. The company said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also found groups with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, populated with images of slimming results, positive testimonials and step-by-step guides for preparing or injecting at residence.

After moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.

Product Information and Pricing

Inside these communities, posts show dark colored packages with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram said it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they can’t verify. Even if the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to possibly significant medical dangers”.